利米特羅

利米特羅
臨床資料
懷孕分級	澳: A ; ;
ATC碼	R03AC05 (WHO) ;
法律規範狀態
法律規範	澳：限醫生處方（S4）;
識別資訊
	IUPAC命名法 4-{(S)-hydroxy[(2R)-piperidin-2-yl]methyl}benzene-1,2-diol; ;
CAS號	32953-89-2
PubChem CID	36283;
ChemSpider	33366 ;
UNII	26GIW6ZLPH;
ChEMBL	ChEMBL1097630 ;
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID70186603 ;
ECHA InfoCard	100.046.627
化學資訊
化學式	C12H17NO3
摩爾質量	223.27 g·mol−1
3D模型（JSmol（英語：JSmol））	交互式圖像;
	SMILES O[C@@H](c1ccc(O)c(O)c1)[C@@H]2NCCCC2;
	InChI InChI=1S/C12H17NO3/c14-10-5-4-8(7-11(10)15)12(16)9-3-1-2-6-13-9/h4-5,7,9,12-16H,1-3,6H2/t9-,12+/m1/s1 ; Key:IYMMESGOJVNCKV-SKDRFNHKSA-N ;

利米特羅（INN：rimiterol）是第三代^[1]短效β₂腎上腺素受體激動劑。^[2]^[3]該藥物可通過靜脈注射或氣霧給藥。^[4]利米特羅可用於治療與支氣管哮喘相關的支氣管痙攣。^[5]^[6]^[7]

參見

參考資料

^ Palma-Carlos AG, Palma-Carlos GS. Beta-2-agonists of third generation. Allergie et Immunologie. April 1986, 18 (4): 31–2, 35. PMID 2899434.
^ Lai CK, Twentyman OP, Holgate ST. The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness. The American Review of Respiratory Disease. October 1989, 140 (4): 917–23. PMID 2572192. doi:10.1164/ajrccm/140.4.917.
^ Ydreborg SO, Svedmyr N, Thiringer G. Comparison of rimiterol and terbutaline, given by aerosol, in a long-term study. Scandinavian Journal of Respiratory Diseases. April 1977, 58 (2): 117–24. PMID 16339.
^ Tarala, R. A.; Martyn, V.; Paterson, J. W. Effect of intravenous injection of rimiterol in asthma. British Journal of Clinical Pharmacology. 1981-09, 12 (3) [2024-03-24]. ISSN 0306-5251. PMC 1401816  . PMID 6117302. doi:10.1111/j.1365-2125.1981.tb01222.x. （原始內容存檔於2024-03-24）.
^ Linehan, W. D. A new bronchodilator, rimiterol hydrobromide (R 798): an open study of the bronchodilator, cardiovascular and arterial oxygen changes in asthmatic patients. Irish Journal of Medical Science. 1975-04, 144 (4) [2024-03-24]. ISSN 0021-1265. PMID 238916. （原始內容存檔於2024-03-24）.
^ Muittari, A. A comparison of rimiterol and salbutamol by inhalation at high and low dose in asthmatic patients. Respiration; International Review of Thoracic Diseases. 1978, 35 (3) [2024-03-24]. ISSN 0025-7931. PMID 25466. doi:10.1159/000193873. （原始內容存檔於2024-03-24）.
^ Pinder, R. M.; Brogden, R. N.; Speight, T. M.; Avery, G. S. Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma. Drugs. 1977-08, 14 (2) [2024-03-24]. ISSN 0012-6667. PMID 19226. doi:10.2165/00003495-197714020-00001. （原始內容存檔於2024-03-24）.

這是一篇關於呼吸系統的藥理學小作品。您可以透過編輯或修訂擴充其內容。

[1] Palma-Carlos AG, Palma-Carlos GS. Beta-2-agonists of third generation. Allergie et Immunologie. April 1986, 18 (4): 31–2, 35. PMID 2899434.

[2] Lai CK, Twentyman OP, Holgate ST. The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness. The American Review of Respiratory Disease. October 1989, 140 (4): 917–23. PMID 2572192. doi:10.1164/ajrccm/140.4.917.

[3] Ydreborg SO, Svedmyr N, Thiringer G. Comparison of rimiterol and terbutaline, given by aerosol, in a long-term study. Scandinavian Journal of Respiratory Diseases. April 1977, 58 (2): 117–24. PMID 16339.

[4] Tarala, R. A.; Martyn, V.; Paterson, J. W. Effect of intravenous injection of rimiterol in asthma. British Journal of Clinical Pharmacology. 1981-09, 12 (3) [2024-03-24]. ISSN 0306-5251. PMC 1401816  . PMID 6117302. doi:10.1111/j.1365-2125.1981.tb01222.x. （原始內容存檔於2024-03-24）.

[5] Linehan, W. D. A new bronchodilator, rimiterol hydrobromide (R 798): an open study of the bronchodilator, cardiovascular and arterial oxygen changes in asthmatic patients. Irish Journal of Medical Science. 1975-04, 144 (4) [2024-03-24]. ISSN 0021-1265. PMID 238916. （原始內容存檔於2024-03-24）.

[6] Muittari, A. A comparison of rimiterol and salbutamol by inhalation at high and low dose in asthmatic patients. Respiration; International Review of Thoracic Diseases. 1978, 35 (3) [2024-03-24]. ISSN 0025-7931. PMID 25466. doi:10.1159/000193873. （原始內容存檔於2024-03-24）.

[7] Pinder, R. M.; Brogden, R. N.; Speight, T. M.; Avery, G. S. Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma. Drugs. 1977-08, 14 (2) [2024-03-24]. ISSN 0012-6667. PMID 19226. doi:10.2165/00003495-197714020-00001. （原始內容存檔於2024-03-24）.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

臨床資料


懷孕分級	澳: A
ATC碼	R03AC05 (WHO)
法律規範狀態
法律規範	澳：限醫生處方（S4）
識別資訊
IUPAC命名法 4-{(S)-hydroxy[(2R)-piperidin-2-yl]methyl}benzene-1,2-diol
CAS號	32953-89-2 ^N
PubChem CID	36283
ChemSpider	33366^Y
UNII	26GIW6ZLPH
ChEMBL	ChEMBL1097630^N
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID70186603
ECHA InfoCard	100.046.627
化學資訊
化學式	C₁₂H₁₇NO₃
摩爾質量	223.27 g·mol⁻¹
3D模型（JSmol（英語：JSmol））	交互式圖像
SMILES O[C@@H](c1ccc(O)c(O)c1)[C@@H]2NCCCC2
InChI InChI=1S/C12H17NO3/c14-10-5-4-8(7-11(10)15)12(16)9-3-1-2-6-13-9/h4-5,7,9,12-16H,1-3,6H2/t9-,12+/m1/s1^Y Key:IYMMESGOJVNCKV-SKDRFNHKSA-N^Y